BYRNE JOSEPH A. enters CEN BIOTECH INC with 12.89K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/22/2021ACC: 0001437749-21-009535
DirectorOfficer· Chief Executive Officer
Since Jul 2017
12.89K
Baseline shares
100% direct
12.89K
Direct ownership
1 position
76.12K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned12.89K
Total
12.89K direct12.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 12.89K | Direct |
| Total | 12.89K | 12.89K direct |
Derivative Holdings1
Convertible Note
DirectUnderlying security
Common Stock
Underlying shares
76.12K
Shares owned
N/A
Exercise price
1.6000
Expiration
—
Exercise window
—
Total
Underlying
76.12K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Convertible Note Direct | Common Stock | 1.6000 | — | — | 76.12K | N/A |
| Total | 76.12K | 0.00 | ||||